Related Experiment Video
Updated: Jun 16, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
[Endocarditis due to infection by Paecilomyces variotii]
Juan Manuel Senior1, Clara Saldarriaga
1Sección de Cardiología, Departamento de Medicina Interna, Hospital Universitario San Vicente de Patil, Universidad de Antioquia, Medellín, Colombia. mmbt@une.net.co
Fungal endocarditis, a growing global concern, was successfully treated in a patient with a prosthetic mitral valve. This rare Paecilomyces variotii infection required amphotericin B and valve replacement, overcoming a previously 100% mortality rate.
Area of Science:
- Mycology
- Infectious Diseases
- Cardiology
Background:
- Fungal endocarditis is an emerging cardiac complication with increasing global incidence.
- Prosthetic valves are susceptible to fungal infections, posing significant clinical challenges.
Observation:
- A male patient with a prosthetic mitral valve developed infective endocarditis.
- The causative agent was identified as Paecilomyces variotii, a rare pathogen in this context.
Findings:
- Successful treatment involved a combination of amphotericin B (3670 mg total dose) and prosthetic mitral valve replacement.
- This case represents the seventh reported instance of Paecilomyces variotii endocarditis, contrasting with the previously reported 100% mortality rate.
Implications:
- This case highlights a potentially treatable outcome for a previously fatal condition.
- Effective antifungal therapy and surgical intervention are crucial for managing Paecilomyces variotii endocarditis.
- Further research into fungal endocarditis treatment protocols is warranted.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Myocarditis I: Introduction
Pericarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
